Latest News and Press Releases
Want to stay updated on the latest news?
-
Agios Pharmaceuticals, Inc. today reported business highlights and financial results for the first quarter ended March 31, 2025.
-
CORAL GABLES, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,...
-
Essential Pharma strengthens Board with the appointment of Jonathan Arnold as Non-Executive Director
Essential Pharma strengthens Board with the appointment of Jonathan Arnold as Non-Executive DirectorEgham, UK – 30 April 2025 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical...
-
Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced their collaboration with the Child Neurology Society
-
EMA designation provides orphan status to medicines being developed for rare conditions that are intended for the diagnosis, prevention or treatment of diseases affecting fewer than 5 in 10,000 people...
-
- NDA submitted for the treatment of central diabetes insipidus -- Expected 10-month review; commercial preparations underway for a potential Q1 2026 launch – DEER PARK, Ill., April 28, 2025 (GLOBE...
-
EMA designation provides orphan status to medicines being developed for rare conditions that are intended for the diagnosis, prevention or treatment of diseases affecting fewer than 5 in 10,000 people...
-
Actum Pharma Expands Executive Team to Launch Enhanced Services Program to Support Biopharma Product Commercialization and Market Success
-
AscellaHealth Announces Key Executive Promotions, Supporting Strategic Growth in the Life Sciences Business Unit
-
JBMR Plus Publication Demonstrating Real-World Impact of ENPP1 Deficiency